HomeXSPRAY • STO
add
XSpray Pharma AB (publ)
Previous close
kr 30.85
Day range
kr 30.75 - kr 31.70
Year range
kr 22.59 - kr 64.10
Market cap
1.29B SEK
Avg Volume
63.35K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 44.69M | -45.91% |
Net income | -47.31M | 42.47% |
Net profit margin | — | — |
Earnings per share | -1.25 | 48.77% |
EBITDA | -43.30M | 46.40% |
Effective tax rate | 0.05% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 197.98M | 164.83% |
Total assets | 820.20M | 22.84% |
Total liabilities | 178.47M | 117.37% |
Total equity | 641.73M | — |
Shares outstanding | 41.74M | — |
Price to book | 2.01 | — |
Return on assets | -14.73% | — |
Return on capital | -16.79% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -47.31M | 42.47% |
Cash from operations | -41.35M | -0.19% |
Cash from investing | -6.86M | 24.17% |
Cash from financing | 172.32M | 12,295.05% |
Net change in cash | 124.18M | 339.66% |
Free cash flow | -36.01M | -89.82% |
About
Founded
2003
Website
Employees
26
